88 related articles for article (PubMed ID: 7613498)
1. The acute effect of perindopril upon effort capacity in congestive heart failure.
Zdrenghea D; Angheloiu O; Icusca G; Timiş D
Rom J Intern Med; 1994; 32(4):265-9. PubMed ID: 7613498
[TBL] [Abstract][Full Text] [Related]
2. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
[TBL] [Abstract][Full Text] [Related]
3. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
Clin Exp Hypertens A; 1989; 11 Suppl 2():575-86. PubMed ID: 2691130
[TBL] [Abstract][Full Text] [Related]
4. [Perindopril and chronic heart failure].
Bounhoure JP
Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
[TBL] [Abstract][Full Text] [Related]
5. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
Sami MH
Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
Sami M
Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
[TBL] [Abstract][Full Text] [Related]
7. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)].
Tereshchenko SN; Kobalova ZhD; Demidova IV; Moiseev VS
Ter Arkh; 1997; 69(12):40-3. PubMed ID: 9503533
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716
[TBL] [Abstract][Full Text] [Related]
9. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
Navookarasu NT; Rahman AR; Abdullah I
Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
[TBL] [Abstract][Full Text] [Related]
10. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
11. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function.
Poelzl G; Frick M; Lackner B; Huegel H; Alber HF; Mair J; Herold M; Schwarzacher SP; Pachinger O; Weidinger F
Int J Cardiol; 2006 Mar; 108(1):48-54. PubMed ID: 16516697
[TBL] [Abstract][Full Text] [Related]
12. Exercise-induced ventricular arrhythmias in congestive heart failure and role of ACE inhibitors.
Hasija PK; Karloopia SD; Shahi BN; Chauhan SS
J Assoc Physicians India; 1998 Feb; 46(2):189-93. PubMed ID: 11273109
[TBL] [Abstract][Full Text] [Related]
13. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
[TBL] [Abstract][Full Text] [Related]
15. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
[TBL] [Abstract][Full Text] [Related]
16. [The long-term administration of perindopril improves the hemodynamic status of rats with heart failure].
Medvedev OS; Zakharova NV
Eksp Klin Farmakol; 1994; 57(6):26-9. PubMed ID: 7756952
[TBL] [Abstract][Full Text] [Related]
17. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
Northridge DB; Currie PF; Newby DE; McMurray JJ; Ford M; Boon NA; Dargie HJ
Eur J Heart Fail; 1999 Mar; 1(1):67-72. PubMed ID: 10937982
[TBL] [Abstract][Full Text] [Related]
20. Cold temperature impairs maximal exercise performance in patients with heart failure: attenuation by acute ACE inhibitor therapy.
Juneau M; Larivée L; White M
Can J Cardiol; 2002 Sep; 18(9):981-6. PubMed ID: 12368933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
